Cm Management, LLC Theravance Biopharma, Inc. Transaction History

Cm Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$8.41 - $10.34 $1.01 Million - $1.24 Million	-120,000 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$8.33 - $12.96 $583,100 - $907,200	70,000 Added 140.0%	120,000 $1.15 Million
Q4 2021 Feb 02, 2022	SELL	$7.42 - $11.05 $371,000 - $552,500	-50,000 Reduced 50.0%	50,000 $553,000
Q3 2021 Nov 08, 2021	BUY	$6.77 - $14.41 $338,500 - $720,500	50,000 Added 100.0%	100,000 $740,000
Q1 2021 May 12, 2021	BUY	$16.57 - $21.08 $828,500 - $1.05 Million	50,000 New	50,000 $1.02 Million

124

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $626M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.